EV Biologics Inc (YECO)
0.6021
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
EV Biologics Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2016 | -6.301M |
| September 30, 2016 | -0.4826M |
| June 30, 2016 | 10.62M |
| March 31, 2016 | 10.54M |
| December 31, 2015 | 9.331M |
| September 30, 2015 | 1.215M |
| Date | Value |
|---|---|
| June 30, 2015 | -7.594M |
| March 31, 2015 | -10.28M |
| December 31, 2014 | -6.530M |
| September 30, 2014 | 3.735M |
| June 30, 2014 | 0.1765M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| CEL-SCI Corp | 8.678M |
| AIM ImmunoTech Inc | 0.485M |
| IGC Pharma Inc | 2.856M |
| NovaBay Pharmaceuticals Inc | 1.91M |
| Protalix BioTherapeutics Inc | 24.67M |